Laidlaw Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Laidlaw Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$477K	Buy
2024 Q3	$501K	Sell
2024 Q2	$483K	Sell
2024 Q1	$504K	Buy
2023 Q4	$337K	Sell
2023 Q3	$488K	Sell
2023 Q2	$611K	Buy
2023 Q1	$563K	Buy
2022 Q4	$521K	Buy